ALEXANDRIA REAL ESTATE EQUITIES, INC. Q3 FY2026 earnings call

• Leasing Momentum: Leased 1.236 million square feet in Q3 2026, the highest volume in seven quarters. 451,000 square feet came from previously vacant space, marking the second-largest quarterly total in company history. Public biotech leasing remained muted at 1.1% of total volume.
• Capital Plan Execution: Completed $1.7 billion in capital activities since June 30, including a $1 billion junior subordinated notes offering (receiving 50% equity credit), a $475 million joint venture at Campus Point, and $234 million in dispositions. Pending dispositions total $2.6 billion, exceeding the $1.9 billion midpoint guidance.
• Balance Sheet Strength: Maintained strong liquidity of $4.6 billion and extended the $5 billion credit line to 2032. The weighted average remaining debt term is over 11.5 years, the longest among S&P 500 REITs. Debt maturities next year are only $350 million.
• Asset Monetization & Impairments: Recognized $638 million in real estate impairments, primarily related to development projects like 421 Park Drive and office-to-lab conversion opportunities in Palo Alto. Non-income producing assets as a percentage of gross assets declined from 20% in late 2024 to 12% in Q3 2026.
• Operational Efficiency: General and administrative expenses were managed prudently, with G&A as a percentage of NOI at 7.5%, roughly half the S&P 500 REIT average. Same property NOI declined 6.7% (GAAP) and 2.8% (cash basis), driven by lower occupancy.
• Strategic Pivot: Increasing focus on advanced technology tenants who value infrastructure and campus amenities. Projects like 311 Arsenal are being pivoted to lower-cost advanced technology execution, reducing future construction needs.

The transcript does not provide a breakdown of financial performance by specific product segments (e.g., Life Science vs. Advanced Technology) in terms of absolute revenue or percentage contribution. It highlights that 74% of leasing volume was from existing tenants and notes the strategic shift toward advanced technology tenants for certain assets, but no segment-specific financial metrics are reported.

• FFO per Share: Reaffirmed the midpoint of 2026 diluted FFO per share guidance at $6.40, tightening the range to +/- $0.02. Lowered realized investment gains guidance by $10 million (midpoint now $65 million) due to transaction timing shifts to 2027.
• Occupancy: No changes to year-end 2026 occupancy guidance. Expected to be around 87.1%.
• Same Property Performance: No changes to guidance for rental rate changes or same property performance; however, management noted 2027 will likely see negative same property performance driven by occupancy headwinds, with improvement expected in 2028.
• Leverage: On track to meet the 2026 leverage target of 5.6 to 6.2 times net debt to annualized adjusted EBITDA. Intermediate goal is mid-five times.
• Construction Spending: Expects average real estate basis capitalized to bottom in Q4 2026. Refinement of 2027 construction spending ($1.15-$1.65 billion prior estimate) will be provided at the December Investor Day.

• Tenant Wind-downs: Expectations of tenant wind-downs impacting 2027 occupancy, similar to 2026 levels ($30-35 million impact). These are difficult to predict but are conservatively estimated based on current underwriting.
• Occupancy Pressure: Temporary pressure on occupancy in H1 2027 due to 1.4 million square feet of key lease expirations with significant downtime (9-24 months). This includes major move-outs like Bristol-Myers at Campus Point.
• Public Biotech Health: Public biotech valuations remain below historical averages, creating uncertainty for this tenant segment, though institutional demand has returned.
• Impairment Risks: Potential for further impairments in 2027 if assets currently held for use meet 'held for sale' accounting requirements due to market values below carrying values.
• Macro Uncertainty: Broader macroeconomic factors and interest rates continue to pressure asset pricing, particularly for non-core assets.

Q: Jim Kammert asked about the cash flow structure of the Campus Point joint venture, specifically regarding fixed cadences and IRR targets for the partner.

A: Marc Binda explained that there is a minimum 5.5% distribution to the partner for the first several years, with steps increasing over time. He clarified that a put mechanism exists to allow the investor to achieve their targeted IRR, while Alexandria retains control via a call option.

Q: Farrell Grunoth sought details on the nature of the tenant wind-down expectations for 2027, asking if these were conservative estimates or based on known moves.

A: Marc Binda stated these are best-guess estimates as wind-downs are hard to predict, noting that deferred rent is written off upon vacating. Joel Marcus added that recent corporate mergers and aggressive venture debt calls have created episodic risks different from past cycles, justifying a conservative approach.

Q: Ronald Kamdem asked for clarification on the treatment of the Campus Point JV for leverage calculations and whether returns were guaranteed.

A: Marc Binda confirmed the JV is treated as permanent equity, consolidated on the balance sheet, and included in leverage computations. Peter Moglia corrected the record, stating returns are not guaranteed, emphasizing the 5.5% minimum is a baseline, not a fixed return guarantee.

Q: Seth Bergey inquired about current cap rates for core assets given macro uncertainty and how JVs factor into leverage targets.

A: Peter Moglia indicated tier-one core assets face pressure but high-quality assets like Campus Point should maintain a five-handle cap rate, while better assets trade at six-handles and workhorse assets at seven-and-a-half to eight-and-a-half. Marc Binda confirmed JVs are consolidated for leverage purposes.

Q: John Kim asked how same-store NOI is expected to improve from 2027 to 2028 despite known move-outs and tenant wind-downs.

A: Marc Binda emphasized that achieving occupancy growth in 2028 requires continued healthy leasing pace, particularly for previously vacant space, citing the strong Q3 performance as a positive indicator. He noted that accumulating leased space with delivery lags supports the outlook for 2028 recovery.